Comparative analyses of the 9 glycoprotein genes found in wild-type and vaccine strains of varicella-zoster virus

Journal of Infectious Diseases

Volumn 197, Issue SUPPL. 2, 2008, Pages

  Storlie, Johnathan ^a   Maresova, Lucie ^a   Jackson, Wallen ^a   Grose, Charles ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; GLYCOPROTEIN B; GLYCOPROTEIN E; GLYCOPROTEIN K; GLYCOPROTEIN L; GLYCOPROTEIN M; GLYCOPROTEIN N; PROTEIN C; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; CODON; CONFERENCE PAPER; CONTROLLED STUDY; DNA SEQUENCE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOMICS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM; STRAIN IDENTIFICATION; VARICELLA ZOSTER VIRUS; VIRUS STRAIN;

CHICKENPOX VACCINE; GENOMICS; HERPESVIRUS 3, HUMAN; HUMANS; OPEN READING FRAMES; POLYMORPHISM, SINGLE NUCLEOTIDE; VIRAL ENVELOPE PROTEINS;

EID: 42549096109     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/522127     Document Type: Conference Paper

References (25)

1. Davison AJ, Scott JE. The complete DNA sequence of varicella-zoster virus. J Gen Virol 1986; 67:1759-816.
2. Grose C. Varicella zoster virus: out of Africa and into the research laboratory. Herpes 2006; 13:32-6.
3. Arvin AM, Gershon AA. Live attenuated varicella vaccine. Annu Rev Microbiol 1996; 50:59-100.
4. Takahashi M. Effectiveness of live varicella vaccine. Expert Opin Biol Ther 2004; 4:199-216.
5. Grose C. Varicella vaccination of children in the United States: assessment after the first decade 1995-2005. J Clin Virol 2005; 33:89-95; discussion, 96-8.
6. Hambleton S, Gershon AA. The impact of varicella vaccination in the United States. Semin Pediatr Infect Dis 2005; 16:38-43.
7. Gomi Y, Sunamachi H, Mori Y, Nagaike K, Takahashi M, Yamanishi K. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol 2002; 76:11447-59.
8. Grose C, Tyler S, Peters G, et al. Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype. J Virol 2004; 78:6799-807.
9. Maresova L, Pasieka T, Wagenaar T, Jackson W, Grose C. Identification of the authentic varicella-zoster virus gB (gene 31) initiating methionine overlapping the 3′ end of gene 30. J Med Virol 2003; 70(Suppl 1):S64-70.
10. Grose C. The predominant varicella-zoster virus gE and gI glycoprotein complex. In: Holzenburg A, Bogner E, eds. Structure-function relationships of human pathogenic viruses. New York: Kluwer Academic Press, 2002:195-223.
11. Wirgart BZ, Estrada V, Jackson W, Linde A, Grose C. A novel varicellazoster virus gE mutation discovered in two Swedish isolates. J Clin Virol 2006; 37:134-6.
12. Natoli S, Ciotti M, Paba P, et al. A novel mutation of varicella-zoster virus associated to fatal hepatitis. J Clin Virol 2006; 37:72-4.
13. Kinchington PR, Ling P, Pensiero M, Moss B, Ruyechan WT, Hay J. The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka). J Virol 1990; 64: 4540-8.
14. Storlie J, Jackson W, Crow J, Grose C. Delayed biosynthesis of varicella-zoster virus glycoprotein C: upregulation by hexamethylene bisacetamide and retinoic acid treatment of infected cells. J Virol 2006; 80:9544-56.
15. Forghani B, Ni L, Grose C. Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology 1994; 199:458-62.
16. Forghani B, Dupuis KW, Schmidt NJ. Epitopes functional in neutralization of varicella-zoster virus. J Clin Microbiol 1990; 28:2500-6.
17. Duus KM, Grose C. Multiple regulatory effects of varicella-zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH. J Virol 1996; 70:8961-71.
18. Mo C, Suen J, Sommer M, Arvin A. Characterization of Varicella-Zoster virus glycoprotein K (open reading frame 5) and its role in virus growth. J Virol 1999; 73:4197-207.
19. Ross J, Williams M, Cohen JI. Disruption of the varicella-zoster virus dUTPase and the adjacent ORF9A gene results in impaired growth and reduced syncytia formation in vitro. Virology 1997; 234:186-95.
20. Padilla JA, Grose C. Varicella-zoster virus with a lost gE epitope: evidence for immunological pressure by the human antibody response. Arch Virol Suppl 2001; (17):27-39.
21. Santos RA, Hatfield CC, Cole NL, et al. Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology 2000; 275:306-17.
22. Loparev VN, Gonzalez A, Deleon-Carnes M, et al. Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J Virol 2004; 78:8349-58.
23. Muir WB, Nichols R, Breuer J. Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J Virol 2002; 76:1971-9.
24. Wagenaar TR, Chow VT, Buranathai C, Thawatsupha P, Grose C. The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/ North American clades. Vaccine 2003; 21:1072-81.
25. Peters G, Tyler S, Grose C, et al. A full genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades. J Virol 2006; 80:9850-60.